1. Home
  2. GERN vs MOFG Comparison

GERN vs MOFG Comparison

Compare GERN & MOFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • MOFG
  • Stock Information
  • Founded
  • GERN 1990
  • MOFG 1934
  • Country
  • GERN United States
  • MOFG United States
  • Employees
  • GERN N/A
  • MOFG N/A
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • MOFG Major Banks
  • Sector
  • GERN Health Care
  • MOFG Finance
  • Exchange
  • GERN Nasdaq
  • MOFG Nasdaq
  • Market Cap
  • GERN 740.5M
  • MOFG 628.8M
  • IPO Year
  • GERN 1996
  • MOFG N/A
  • Fundamental
  • Price
  • GERN $1.12
  • MOFG $39.32
  • Analyst Decision
  • GERN Buy
  • MOFG Buy
  • Analyst Count
  • GERN 7
  • MOFG 2
  • Target Price
  • GERN $3.00
  • MOFG $40.50
  • AVG Volume (30 Days)
  • GERN 8.6M
  • MOFG 371.1K
  • Earning Date
  • GERN 11-05-2025
  • MOFG 10-23-2025
  • Dividend Yield
  • GERN N/A
  • MOFG 2.47%
  • EPS Growth
  • GERN N/A
  • MOFG N/A
  • EPS
  • GERN N/A
  • MOFG 2.81
  • Revenue
  • GERN $183,403,000.00
  • MOFG $221,843,000.00
  • Revenue This Year
  • GERN $166.20
  • MOFG $240.57
  • Revenue Next Year
  • GERN $55.83
  • MOFG $6.57
  • P/E Ratio
  • GERN N/A
  • MOFG $13.96
  • Revenue Growth
  • GERN 522.13
  • MOFG 504.86
  • 52 Week Low
  • GERN $1.04
  • MOFG $24.62
  • 52 Week High
  • GERN $4.21
  • MOFG $40.25
  • Technical
  • Relative Strength Index (RSI)
  • GERN 40.96
  • MOFG 72.19
  • Support Level
  • GERN $1.04
  • MOFG $38.45
  • Resistance Level
  • GERN $1.28
  • MOFG $39.90
  • Average True Range (ATR)
  • GERN 0.07
  • MOFG 1.11
  • MACD
  • GERN 0.00
  • MOFG 0.03
  • Stochastic Oscillator
  • GERN 30.12
  • MOFG 85.42

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About MOFG MidWestOne Financial Gp

MidWestOne Financial Group Inc is a bank holding company engaged in delivering relationship-based business and personal banking products and services. The Bank provides commercial loans, real estate loans, agricultural loans, credit card loans, and consumer loans. It also provides deposit products including demand and interest checking accounts, savings accounts, money market accounts, and time deposits. The Bank also provides products and services including treasury management, Zelle, online and mobile banking, debit cards, ATMs, and safe deposit boxes. The Bank offers its products and services through its network of full-service banking offices. the Bank's investments services department offers financial planning, investment advisory, and retail securities brokerage services.

Share on Social Networks: